{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T17:31:11Z","timestamp":1786383071353,"version":"build-2736575974"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06121-2","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:45:54Z","timestamp":1786376754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Amino Acid\u2013Neurodegeneration Axis: Excitotoxicity and Oxidative Stress as Context-Dependent Amplifiers of Metabolic Dysfunction"],"prefix":"10.1007","volume":"63","author":[{"given":"Precious Adeoye","family":"Oyedokun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua Oluwasola","family":"Gbadero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Ishola","family":"Ajao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayowa Damilola","family":"Olorunsesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayanfeoluwa Isaac","family":"Oyesiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon Opeyemi","family":"Ayilara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvellous Kehinde","family":"Ogunsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blessing Stephany","family":"Justus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimoh Motunrayo","family":"Ademola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Adebusola","family":"Adetunji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Precious Sunday","family":"Okodio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel Ohiemi","family":"Amedu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"17","key":"6121_CR1","doi-asserted-by":"publisher","first-page":"6197","DOI":"10.3390\/ijms21176197","volume":"21","author":"R Dalangin","year":"2020","unstructured":"Dalangin R, Kim A, Campbell RE (2020) The role of amino acids in neurotransmission and fluorescent tools for their detection. Int J Mol Sci 21(17):6197","journal-title":"Int J Mol Sci"},{"key":"6121_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2020.104809","volume":"140","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Eid T, Hassel B, Danbolt NC (2020) Novel aspects of glutamine synthetase in ammonia homeostasis. Neurochem Int 140:104809","journal-title":"Neurochem Int"},{"key":"6121_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102357","volume":"99","author":"DG Gadhave","year":"2024","unstructured":"Gadhave DG, Sugandhi VV, Jha SK, Nangare SN, Gupta G, Singh SK, Dua K, Cho H et al (2024) Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance. Ageing Res Rev 99:102357","journal-title":"Ageing Res Rev"},{"key":"6121_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105771","volume":"177","author":"SK Adla","year":"2024","unstructured":"Adla SK, Virtanen H, Thongsodsaeng T, Huttunen KM (2024) Amino acid transporters in neurological disorders and neuroprotective effects of cysteine derivatives. Neurochem Int 177:105771","journal-title":"Neurochem Int"},{"issue":"12","key":"6121_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.108004","volume":"300","author":"CR Green","year":"2024","unstructured":"Green CR, Alaeddine LM, Wessendorf-Rodriguez KA, Turner R, Elmastas M, Hover JD, Murphy AN, Ryden M et al (2024) Impaired branched-chain amino acid (BCAA) catabolism during adipocyte differentiation decreases glycolytic flux. J Biol Chem 300(12):108004","journal-title":"J Biol Chem"},{"key":"6121_CR6","doi-asserted-by":"publisher","unstructured":"Todd AC, Hardingham GE (2020) The regulation of astrocytic glutamate transporters in health and neurodegenerative diseases.\u00a0Int J Mol Sci 21(24):9607. https:\/\/doi.org\/10.3390\/ijms21249607","DOI":"10.3390\/ijms21249607"},{"key":"6121_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2015.00091","volume":"9","author":"J Blesa","year":"2015","unstructured":"Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR (2015) Oxidative stress and Parkinson\u2019s disease. Front Neuroanat 9:91","journal-title":"Front Neuroanat"},{"issue":"13","key":"6121_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cells11132049","volume":"11","author":"J Zhao","year":"2022","unstructured":"Zhao J, Wang X, Huo Z, Chen Y, Liu J, Zhao Z, Meng F, Su Q et al (2022) The impact of mitochondrial dysfunction in amyotrophic lateral sclerosis. Cells 11(13):2049","journal-title":"Cells"},{"issue":"9","key":"6121_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092488","volume":"11","author":"VJ Clemente-Su\u00e1rez","year":"2023","unstructured":"Clemente-Su\u00e1rez VJ, Redondo-Fl\u00f3rez L, Beltr\u00e1n-Velasco AI, Ramos-Campo DJ, Belinch\u00f3n-deMiguel P, Martinez-Guardado I, Dalamitros AA, Y\u00e1\u00f1ez-Sep\u00falveda R et al (2023) Mitochondria and brain disease: a comprehensive review of pathological mechanisms and therapeutic opportunities. Biomedicines 11(9):2488","journal-title":"Biomedicines"},{"issue":"2","key":"6121_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10020229","volume":"10","author":"J Woo","year":"2021","unstructured":"Woo J, Cho H, Seol Y, Kim SH, Park C, Yousefian-Jazi A, Hyeon SJ, Lee J et al (2021) Power failure of mitochondria and oxidative stress in neurodegeneration and its computational models. Antioxidants (Basel) 10(2):229","journal-title":"Antioxidants (Basel)"},{"key":"6121_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.530219","volume":"14","author":"X Yan","year":"2020","unstructured":"Yan X, Hu Y, Wang B, Wang S, Zhang X (2020) Metabolic dysregulation contributes to the progression of Alzheimer\u2019s disease. Front Neurosci 14:530219","journal-title":"Front Neurosci"},{"key":"6121_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3389\/fphys.2020.00973","volume":"11","author":"R Zaragoz\u00e1","year":"2020","unstructured":"Zaragoz\u00e1 R (2020) Transport of amino acids across the blood-brain barrier. Front Physiol 11:973","journal-title":"Front Physiol"},{"issue":"3","key":"6121_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101846","volume":"13","author":"T Liu","year":"2025","unstructured":"Liu T, Rong Z, Li J, Wu H, Wei J (2025) Three-dimensional interactive network: mitochondrial-metabolic-calcium homeostasis driving Alzheimer\u2019s disease. Genes Dis 13(3):101846","journal-title":"Genes Dis"},{"key":"6121_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1604378","volume":"17","author":"K Zhang","year":"2025","unstructured":"Zhang K, Wen M, Nan X, Zhao S, Li H, Ai Y, Zhu H (2025) NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies. Front Aging Neurosci 17:1604378","journal-title":"Front Aging Neurosci"},{"key":"6121_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2025.1644633","volume":"5","author":"X Zhang","year":"2025","unstructured":"Zhang X, Fu M, Wang Y, Wu T (2025) Strategies for delivering drugs across the blood-brain barrier for the treatment of neurodegenerative diseases. Front Drug Deliv 5:1644633","journal-title":"Front Drug Deliv"},{"issue":"11","key":"6121_CR16","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.3390\/ijms23115954","volume":"23","author":"RI Teleanu","year":"2022","unstructured":"Teleanu RI, Niculescu A-G, Roza E, Vlad\u00e2cenco O, Grumezescu AM, Teleanu DM (2022) Neurotransmitters\u2014key factors in neurological and neurodegenerative disorders of the central nervous system. Int J Mol Sci 23(11):5954","journal-title":"Int J Mol Sci"},{"issue":"5","key":"6121_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051226","volume":"10","author":"F Lange","year":"2021","unstructured":"Lange F, H\u00f6rnschemeyer MF, Kirschstein T (2021) Glutamatergic mechanisms in glioblastoma and tumor-associated epilepsy. Cells 10(5):1226","journal-title":"Cells"},{"issue":"2","key":"6121_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/febs.15842","volume":"289","author":"CD Poltorack","year":"2022","unstructured":"Poltorack CD, Dixon SJ (2022) Understanding the role of cysteine in ferroptosis: progress & paradoxes. FEBS J 289(2):374\u2013385","journal-title":"FEBS J"},{"issue":"4","key":"6121_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.9758\/cpn.2020.18.4.507","volume":"18","author":"A Muneer","year":"2020","unstructured":"Muneer A (2020) Kynurenine pathway of tryptophan metabolism in neuropsychiatric disorders: pathophysiologic and therapeutic considerations. Clin Psychopharmacol Neurosci 18(4):507","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"6","key":"6121_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/biom10060863","volume":"10","author":"MA Bhat","year":"2020","unstructured":"Bhat MA, Ahmad K, Khan MSA, Bhat MA, Almatroudi A, Rahman S, Jan AT (2020) Expedition into taurine biology: structural insights and therapeutic perspective of taurine in neurodegenerative diseases. Biomolecules 10(6):863","journal-title":"Biomolecules"},{"key":"6121_CR21","doi-asserted-by":"crossref","unstructured":"Patri M (2019) Synaptic transmission and amino acid neurotransmitters. In: Neurochemical basis of brain function and dysfunction. IntechOpen","DOI":"10.5772\/intechopen.82121"},{"issue":"22","key":"6121_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225671","volume":"20","author":"AR Malik","year":"2019","unstructured":"Malik AR, Willnow TE (2019) Excitatory amino acid transporters in physiology and disorders of the central nervous system. Int J Mol Sci 20(22):5671","journal-title":"Int J Mol Sci"},{"key":"6121_CR23","volume-title":"Electrophysiological characterization of NMDA receptor modulation by its co-agonists","author":"JM Wong","year":"2020","unstructured":"Wong JM (2020) Electrophysiological characterization of NMDA receptor modulation by its co-agonists. University of California, Davis"},{"issue":"10","key":"6121_CR24","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3390\/ijms17101636","volume":"17","author":"L Zheng","year":"2016","unstructured":"Zheng L, Zhang W, Zhou Y, Li F, Wei H, Peng J (2016) Recent advances in understanding amino acid sensing mechanisms that regulate mTORC1. Int J Mol Sci 17(10):1636","journal-title":"Int J Mol Sci"},{"key":"6121_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-030-45328-2_10","volume-title":"Amino acids in nutrition and health: amino acids in systems function and health","author":"W He","year":"2020","unstructured":"He W, Wu G (2020) Metabolism of amino acids in the brain and their roles in regulating food intake. Amino acids in nutrition and health: amino acids in systems function and health. pp 167\u2013185"},{"issue":"2","key":"6121_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/jnc.15811","volume":"166","author":"JV Andersen","year":"2023","unstructured":"Andersen JV, Schousboe A (2023) Milestone review: metabolic dynamics of glutamate and GABA mediated neurotransmission\u2014the essential roles of astrocytes. J Neurochem 166(2):109\u2013137","journal-title":"J Neurochem"},{"key":"6121_CR27","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00050.2017","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV (2018) Blood-brain barrier: from physiology to disease and back. Physiol Rev. https:\/\/doi.org\/10.1152\/physrev.00050.2017","journal-title":"Physiol Rev"},{"issue":"11","key":"6121_CR28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/metabo10110450","volume":"10","author":"JW B\u0142aszczyk","year":"2020","unstructured":"B\u0142aszczyk JW (2020) Energy metabolism decline in the aging brain\u2014pathogenesis of neurodegenerative disorders. Metabolites 10(11):450","journal-title":"Metabolites"},{"issue":"44","key":"6121_CR29","doi-asserted-by":"publisher","first-page":"9318","DOI":"10.1523\/JNEUROSCI.2119-18.2018","volume":"38","author":"D Choquet","year":"2018","unstructured":"Choquet D (2018) Linking nanoscale dynamics of AMPA receptor organization to plasticity of excitatory synapses and learning. J Neurosci 38(44):9318\u20139329","journal-title":"J Neurosci"},{"issue":"10","key":"6121_CR30","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3390\/ph17101265","volume":"17","author":"M Beaurain","year":"2024","unstructured":"Beaurain M, Salabert AS, Payoux P, Gras E, Talmont F (2024) NMDA receptors: distribution, role, and insights into neuropsychiatric disorders. Pharmaceuticals (Basel) 17(10):1265","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"6121_CR31","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/antiox11050801","volume":"11","author":"D Matuz-Mares","year":"2022","unstructured":"Matuz-Mares D, Gonz\u00e1lez-Andrade M, Araiza-Villanueva MG, Vilchis-Landeros MM, V\u00e1zquez-Meza H (2022) Mitochondrial calcium: effects of its imbalance in disease. Antioxidants (Basel, Switzerland) 11(5):801. https:\/\/doi.org\/10.3390\/antiox11050801","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"6121_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-3-319-55769-4_4","volume-title":"Glial amino acid transporters","author":"F Zafra","year":"2017","unstructured":"Zafra F, Ib\u00e1\u00f1ez I, Bartolom\u00e9-Mart\u00edn D, Piniella D, Arribas-Bl\u00e1zquez M, Gim\u00e9nez C (2017) Glycine transporters and its coupling with NMDA receptors. Glial amino acid transporters. pp 55\u201383"},{"key":"6121_CR33","doi-asserted-by":"publisher","unstructured":"Alkaissi H, McFarlane SI (2023) Hyperhomocysteinemia and accelerated aging: the pathogenic role of increased homocysteine in atherosclerosis, osteoporosis, and neurodegeneration. Cureus 15(7):e42259. https:\/\/doi.org\/10.7759\/cureus.42259","DOI":"10.7759\/cureus.42259"},{"issue":"1","key":"6121_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/j.2040-4603.2016.tb00682.x","volume":"6","author":"KS McCully","year":"2016","unstructured":"McCully KS (2016) Homocysteine metabolism, atherosclerosis, and diseases of aging. Compr Physiol 6(1):471\u2013505","journal-title":"Compr Physiol"},{"key":"6121_CR35","doi-asserted-by":"crossref","unstructured":"Kovacs L, Su Y (2017) Redox-dependent calpain signaling in airway and pulmonary vascular remodeling in COPD. Pulmonary vasculature redox signaling in health and disease. Springer International Publishing, Cham, pp 139\u2013160","DOI":"10.1007\/978-3-319-63245-2_9"},{"issue":"3","key":"6121_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/antiox6030062","volume":"6","author":"GJ McBean","year":"2017","unstructured":"McBean GJ (2017) Cysteine, glutathione, and thiol redox balance in astrocytes. Antioxidants 6(3):62","journal-title":"Antioxidants"},{"issue":"41","key":"6121_CR37","doi-asserted-by":"publisher","first-page":"10514","DOI":"10.1523\/JNEUROSCI.3178-06.2006","volume":"26","author":"AY Shih","year":"2006","unstructured":"Shih AY, Erb H, Sun X, Toda S, Kalivas PW, Murphy TH (2006) Cystine\/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci 26(41):10514\u201310523. https:\/\/doi.org\/10.1523\/JNEUROSCI.3178-06.2006","journal-title":"J Neurosci"},{"issue":"4","key":"6121_CR38","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/j.1471-4159.2004.02915.x","volume":"92","author":"K van Leyen","year":"2005","unstructured":"van Leyen K, Siddiq A, Ratan RR, Lo EH (2005) Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity. J Neurochem 92(4):824\u2013830. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02915.x","journal-title":"J Neurochem"},{"issue":"4","key":"6121_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042276","volume":"25","author":"A Vaglio-Garro","year":"2024","unstructured":"Vaglio-Garro A, Kozlov AV, Smirnova YD, Weidinger A (2024) Pathological interplay between inflammation and mitochondria aggravates glutamate toxicity. Int J Mol Sci 25(4):2276","journal-title":"Int J Mol Sci"},{"issue":"7","key":"6121_CR40","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/biom12070998","volume":"12","author":"K Hestad","year":"2022","unstructured":"Hestad K, Alexander J, Rootwelt H, Aaseth JO (2022) The role of tryptophan dysmetabolism and quinolinic acid in depressive and neurodegenerative diseases. Biomolecules 12(7):998","journal-title":"Biomolecules"},{"issue":"1","key":"6121_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-021-00841-3","volume":"11","author":"R Hosoi","year":"2021","unstructured":"Hosoi R, Fujii Y, Hiroyuki O, Shukuri M, Nishiyama S, Kanazawa M, Todoroki K, Arano Y et al (2021) Evaluation of intracellular processes in quinolinic acid-induced brain damage by imaging reactive oxygen species generation and mitochondrial complex I activity. EJNMMI Res 11(1):99. https:\/\/doi.org\/10.1186\/s13550-021-00841-3","journal-title":"EJNMMI Res"},{"key":"6121_CR42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neuro.2021.03.009","volume":"84","author":"RK Sodhi","year":"2021","unstructured":"Sodhi RK, Bansal Y, Singh R, Saroj P, Bhandari R, Kumar B, Kuhad A (2021) IDO-1 inhibition protects against neuroinflammation, oxidative stress and mitochondrial dysfunction in 6-OHDA induced murine model of Parkinson\u2019s disease. Neurotoxicology 84:184\u2013197","journal-title":"Neurotoxicology"},{"key":"6121_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00457","volume":"13","author":"\u0160 Lehtonen","year":"2019","unstructured":"Lehtonen \u0160, Sonninen TM, Wojciechowski S, Goldsteins G, Koistinaho J (2019) Dysfunction of cellular proteostasis in Parkinson\u2019s disease. Front Neurosci 13:457","journal-title":"Front Neurosci"},{"issue":"3","key":"6121_CR44","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3164\/jcbn.25-74","volume":"77","author":"Y Kato","year":"2025","unstructured":"Kato Y, Kanatani M, Adachi T, Nagamine H, Horikoshi Y, Nakaso K (2025) Oxidative modification of methionine residue in \u03b1-synuclein by dopamine induces cellular vulnerability, oligomerization and secretion of \u03b1-synuclein. J Clin Biochem Nutr 77(3):216\u2013222. https:\/\/doi.org\/10.3164\/jcbn.25-74","journal-title":"J Clin Biochem Nutr"},{"key":"6121_CR45","doi-asserted-by":"crossref","unstructured":"Goffredo D, Rigamonti D, Tartari M, De Micheli A, Verderio C, Matteoli M, ... Cattaneo E (2002) Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons. J Biol Chem 277(42):39594\u201339598","DOI":"10.1074\/jbc.C200353200"},{"issue":"4","key":"6121_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010139","volume":"5","author":"MS Baptista","year":"2010","unstructured":"Baptista MS, Melo CV, Armel\u00e3o M, Herrmann D, Pimentel DO, Leal G, Caldeira MV, Bahr BA et al (2010) Role of the proteasome in excitotoxicity-induced cleavage of glutamic acid decarboxylase in cultured hippocampal neurons. PLoS ONE 5(4):e10139. https:\/\/doi.org\/10.1371\/journal.pone.0010139","journal-title":"PLoS ONE"},{"key":"6121_CR47","doi-asserted-by":"crossref","unstructured":"Sun H, Li M, Li Y, Zheng N, Li J, Li X, ... Zou L (2024) Gastrodin improves the activity of the ubiquitin\u2013proteasome system and the autophagy\u2013lysosome pathway to degrade mutant huntingtin. Int J Mol Sci 25(14):7709","DOI":"10.3390\/ijms25147709"},{"issue":"23","key":"6121_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236004","volume":"20","author":"RP Ureshino","year":"2019","unstructured":"Ureshino RP, Erustes AG, Bassani TB, Wachilewski P, Guarache GC, Nascimento AC, Costa AJ, Smaili SS et al (2019) The interplay between Ca2+ signaling pathways and neurodegeneration. Int J Mol Sci 20(23):6004","journal-title":"Int J Mol Sci"},{"issue":"5","key":"6121_CR49","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.tins.2021.01.001","volume":"44","author":"N Plotegher","year":"2021","unstructured":"Plotegher N, Filadi R, Pizzo P, Duchen MR (2021) Excitotoxicity revisited: mitochondria on the verge of a nervous breakdown. Trends Neurosci 44(5):342\u2013351. https:\/\/doi.org\/10.1016\/j.tins.2021.01.001","journal-title":"Trends Neurosci"},{"issue":"1","key":"6121_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00636-1","volume":"18","author":"SP Yu","year":"2023","unstructured":"Yu SP, Jiang MQ, Shim SS, Pourkhodadad S, Wei L (2023) Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer\u2019s disease. Mol Neurodegener 18(1):43. https:\/\/doi.org\/10.1186\/s13024-023-00636-1","journal-title":"Mol Neurodegener"},{"key":"6121_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2701526","author":"FJ Carvajal","year":"2016","unstructured":"Carvajal FJ, Mattison HA, Cerpa W (2016) Role of NMDA receptor\u2010mediated glutamatergic signaling in chronic and acute neuropathologies. Neural Plast. https:\/\/doi.org\/10.1155\/2016\/2701526","journal-title":"Neural Plast"},{"key":"6121_CR52","doi-asserted-by":"publisher","unstructured":"Talantova M, Sanz-Blasco S, Zhang X, Xia P, Akhtar MW, Okamoto S, Dziewczapolski G, Nakamura T et al (2013) A\u03b2 induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc National Acad Sci 110(27):E2518\u2013E2527. https:\/\/doi.org\/10.1073\/pnas.1306832110","DOI":"10.1073\/pnas.1306832110"},{"key":"6121_CR53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fnmol.2020.00151","volume":"13","author":"EJ Koller","year":"2020","unstructured":"Koller EJ, Chakrabarty P (2020) Tau-mediated dysregulation of neuroplasticity and glial plasticity. Front Mol Neurosci 13:151","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"6121_CR54","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11306-024-02181-4","volume":"20","author":"X Flores-Ponce","year":"2024","unstructured":"Flores-Ponce X, Velasco I (2024) Dopaminergic neuron metabolism: relevance for understanding Parkinson\u2019s disease. Metabolomics 20(6):116","journal-title":"Metabolomics"},{"issue":"3","key":"6121_CR55","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","volume":"144","author":"L Iovino","year":"2020","unstructured":"Iovino L, Tremblay ME, Civiero L (2020) Glutamate-induced excitotoxicity in Parkinson\u2019s disease: the role of glial cells. J Pharmacol Sci 144(3):151\u2013164. https:\/\/doi.org\/10.1016\/j.jphs.2020.07.011","journal-title":"J Pharmacol Sci"},{"issue":"5","key":"6121_CR56","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.tips.2018.02.007","volume":"39","author":"BD Paul","year":"2018","unstructured":"Paul BD, Sbodio JI, Snyder SH (2018) Cysteine metabolism in neuronal redox homeostasis. Trends Pharmacol Sci 39(5):513\u2013524","journal-title":"Trends Pharmacol Sci"},{"key":"6121_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.611735","volume":"8","author":"M Czeredys","year":"2020","unstructured":"Czeredys M (2020) Dysregulation of neuronal calcium signaling via store-operated channels in Huntington\u2019s disease. Front Cell Dev Biol 8:611735","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"6121_CR58","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","volume":"65","author":"AJ Milnerwood","year":"2010","unstructured":"Milnerwood AJ, Gladding CM, Pouladi MA, Kaufman AM, Hines RM, Boyd JD, Ko RWY, Vasuta OC et al (2010) Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington\u2019s disease mice. Neuron 65(2):178\u2013190. https:\/\/doi.org\/10.1016\/j.neuron.2010.01.008","journal-title":"Neuron"},{"issue":"7","key":"6121_CR59","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.4103\/1673-5374.360289","volume":"18","author":"A Jurcau","year":"2023","unstructured":"Jurcau A, Jurcau CM (2023) Mitochondria in Huntington\u2019s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies. Neural Regen Res 18(7):1472\u20131477","journal-title":"Neural Regen Res"},{"issue":"20","key":"6121_CR60","doi-asserted-by":"publisher","first-page":"15430","DOI":"10.3390\/ijms242015430","volume":"24","author":"F Provenzano","year":"2023","unstructured":"Provenzano F, Torazza C, Bonifacino T, Bonanno G, Milanese M (2023) The key role of astrocytes in amyotrophic lateral sclerosis and their commitment to glutamate excitotoxicity. Int J Mol Sci 24(20):15430","journal-title":"Int J Mol Sci"},{"issue":"9","key":"6121_CR61","doi-asserted-by":"publisher","first-page":"8044","DOI":"10.3390\/ijms24098044","volume":"24","author":"J Fujii","year":"2023","unstructured":"Fujii J, Osaki T, Soma Y, Matsuda Y (2023) Critical roles of the cysteine\u2013glutathione axis in the production of \u03b3-glutamyl peptides in the nervous system. Int J Mol Sci 24(9):8044","journal-title":"Int J Mol Sci"},{"issue":"7","key":"6121_CR62","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00702-016-1661-z","volume":"124","author":"M Levite","year":"2017","unstructured":"Levite M (2017) Glutamate, T cells and multiple sclerosis. J Neural Transm 124(7):775\u2013798","journal-title":"J Neural Transm"},{"issue":"8","key":"6121_CR63","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.4103\/1673-5374.274328","volume":"15","author":"B Polis","year":"2020","unstructured":"Polis B, Samson AO (2020) Role of the metabolism of branched-chain amino acids in the development of Alzheimer\u2019s disease and other metabolic disorders. Neural Regen Res 15(8):1460\u20131470","journal-title":"Neural Regen Res"},{"issue":"12","key":"6121_CR64","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/mds.26351","volume":"30","author":"LK Mischley","year":"2015","unstructured":"Mischley LK, Leverenz JB, Lau RC, Polissar NL, Neradilek MB, Samii A, Standish LJ (2015) A randomized, double\u2010blind phase I\/II a study of intranasal glutathione in Parkinson\u2019s disease. Mov Disord 30(12):1696\u20131701","journal-title":"Mov Disord"},{"issue":"12","key":"6121_CR65","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3390\/antiox10121876","volume":"10","author":"PF Surai","year":"2021","unstructured":"Surai PF, Earle-Payne K, Kidd MT (2021) Taurine as a natural antioxidant: from direct antioxidant effects to protective action in various toxicological models. Antioxidants (Basel) 10(12):1876","journal-title":"Antioxidants (Basel)"},{"key":"6121_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2019.109356","volume":"132","author":"MF McCarty","year":"2019","unstructured":"McCarty MF, O\u2019Keefe JH, DiNicolantonio JJ (2019) A diet rich in taurine, cysteine, folate, B12 and betaine may lessen risk for Alzheimer\u2019s disease by boosting brain synthesis of hydrogen sulfide. Med Hypotheses 132:109356","journal-title":"Med Hypotheses"},{"issue":"8","key":"6121_CR67","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.3390\/ijms26083905","volume":"26","author":"H Xing","year":"2025","unstructured":"Xing H, Yue S, Qin R, Du X, Wu Y, Zhangsun D, Luo S (2025) Recent advances in drug development for Alzheimer\u2019s disease: a comprehensive review. Int J Mol Sci 26(8):3905","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6121_CR68","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2174\/1871527318666190112143834","volume":"18","author":"S Zameer","year":"2019","unstructured":"Zameer S, Akhtar M, Vohora D (2019) Behavioral experimental paradigms for the evaluation of drug\u2019s influence on cognitive functions: interpretation of associative, spatial\/nonspatial and working memory. CNS Neurol Disord Drug Targets 18(3):185\u2013204","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"3","key":"6121_CR69","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1527-3458.2003.tb00254.x","volume":"9","author":"MA Rogawski","year":"2003","unstructured":"Rogawski MA, Wenk GL (2003) The neuropharmacological basis for the use of memantine in the treatment of Alzheimer\u2019s disease. CNS Drug Rev 9(3):275\u2013308","journal-title":"CNS Drug Rev"},{"issue":"10","key":"6121_CR70","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1106668","volume":"366","author":"R Howard","year":"2012","unstructured":"Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T et al (2012) Donepezil and memantine for moderate-to-severe Alzheimer\u2019s disease. N Engl J Med 366(10):893\u2013903. https:\/\/doi.org\/10.1056\/NEJMoa1106668","journal-title":"N Engl J Med"},{"issue":"3","key":"6121_CR71","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.18632\/aging.102830","volume":"12","author":"A Vall\u00e9e","year":"2020","unstructured":"Vall\u00e9e A, Vall\u00e9e JN, Guillevin R, Lecarpentier Y (2020) Riluzole: a therapeutic strategy in Alzheimer\u2019s disease by targeting the WNT\/\u03b2-catenin pathway. Aging (Albany NY) 12(3):3095","journal-title":"Aging (Albany NY)"},{"key":"6121_CR72","doi-asserted-by":"publisher","unstructured":"Miller RG, Mitchell JD, Moore DH (2012) Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND). The Cochrane database of systematic reviews 2012(3):CD001447. https:\/\/doi.org\/10.1002\/14651858.CD001447.pub3","DOI":"10.1002\/14651858.CD001447.pub3"},{"issue":"2","key":"6121_CR73","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1021\/acs.molpharmaceut.0c00474","volume":"18","author":"AC Farr","year":"2020","unstructured":"Farr AC, Xiong MP (2020) Challenges and opportunities of deferoxamine delivery for treatment of Alzheimer\u2019s disease, Parkinson\u2019s disease, and intracerebral hemorrhage. Mol Pharm 18(2):593\u2013609","journal-title":"Mol Pharm"},{"key":"6121_CR74","doi-asserted-by":"crossref","unstructured":"Fine JM, Kosyakovsky J, Baillargeon AM, Tokarev JV, Cooner JM, Svitak AL, ... Hanson LR (2020) Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non\u2010disease\u2010specific pathway of functional neurologic improvement. Brain Behav 10(3):e01536","DOI":"10.1002\/brb3.1536"},{"key":"6121_CR75","doi-asserted-by":"crossref","unstructured":"Fine JM, Kosyakovsky J, Bowe TT, Faltesek KA, Stroebel BM, Abrahante JE, ... Hanson LR (2025) Low-dose intranasal deferoxamine modulates memory, neuroinflammation, and the neuronal transcriptome in the streptozotocin rodent model of Alzheimer\u2019s disease. Front Neurosci 18:1528374","DOI":"10.3389\/fnins.2024.1528374"},{"issue":"2","key":"6121_CR76","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10072-024-07880-3","volume":"46","author":"Y Dhurandhar","year":"2025","unstructured":"Dhurandhar Y, Tomar S, Namdeo KP, Bodakhe SH (2025) Excitatory amino acids as therapeutic agents: reversing neurodegenerative trajectory by tackling excitotoxicity. Neurol Sci 46(2):549\u2013560","journal-title":"Neurol Sci"},{"issue":"1","key":"6121_CR77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","volume":"52","author":"EL Lieu","year":"2020","unstructured":"Lieu EL, Nguyen T, Rhyne S, Kim J (2020) Amino acids in cancer. Exp Mol Med 52(1):15\u201330","journal-title":"Exp Mol Med"},{"key":"6121_CR78","doi-asserted-by":"crossref","unstructured":"Kim HY, Kim HV, Yoon JH, Kang BR, Cho SM, Lee S, ... Kim Y (2014) Taurine in drinking water recovers learning and memory in the adult APP\/PS1 mouse model of Alzheimer's disease. Sci Rep 4(1):7467","DOI":"10.1038\/srep07467"},{"issue":"1","key":"6121_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/srep07467","volume":"4","author":"HY Kim","year":"2014","unstructured":"Kim HY, Kim HV, Yoon JH, Kang BR, Cho SM, Lee S, Kim JY, Kim JW et al (2014) Taurine in drinking water recovers learning and memory in the adult APP\/PS1 mouse model of Alzheimer\u2019s disease. Sci Rep 4(1):7467","journal-title":"Sci Rep"},{"key":"6121_CR80","doi-asserted-by":"crossref","unstructured":"Lee H, Hossain MK, Lee HY, Kumar V, Shin SJ, Kim BH, ... Kim HR (2025) Taurine suppresses A\u03b2 aggregation and attenuates Alzheimer\u2019s disease pathologies in 5XFAD mice and patient-derived cerebral organoids. Biomed Pharmacother 191:118527","DOI":"10.1016\/j.biopha.2025.118527"},{"issue":"2","key":"6121_CR81","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/antiox11020416","volume":"11","author":"M Martinez-Banaclocha","year":"2022","unstructured":"Martinez-Banaclocha M (2022) N-acetyl-cysteine: modulating the cysteine redox proteome in neurodegenerative diseases. Antioxidants (Basel) 11(2):416","journal-title":"Antioxidants (Basel)"},{"issue":"02","key":"6121_CR82","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/nep3.46","volume":"2","author":"JY Magdaleno Roman","year":"2024","unstructured":"Magdaleno Roman JY, Gonz\u00e1lez CC (2024) Glutamate and excitotoxicity in central nervous system disorders: ionotropic glutamate receptors as a target for neuroprotection. Neuroprotection 2(02):137\u2013150","journal-title":"Neuroprotection"},{"issue":"8","key":"6121_CR83","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3390\/pharmaceutics17081041","volume":"17","author":"HM Yang","year":"2025","unstructured":"Yang HM (2025) Overcoming the blood\u2013brain barrier: advanced strategies in targeted drug delivery for neurodegenerative diseases. Pharmaceutics 17(8):1041","journal-title":"Pharmaceutics"},{"key":"6121_CR84","doi-asserted-by":"publisher","unstructured":"Mart\u00ed-Carvajal AJ, Sol\u00e0 I, Mart\u00ed-Carvajal GE (2023) Antioxidants for Alzheimer\u2019s disease. Cochrane Database Syst Rev 2023(11):CD013749. https:\/\/doi.org\/10.1002\/14651858.CD013749.pub2","DOI":"10.1002\/14651858.CD013749.pub2"},{"key":"6121_CR85","first-page":"85","volume-title":"Two sides of the same coin \u2013 neurotransmitters in health and disease","author":"A Baig","year":"2025","unstructured":"Baig A, Tanveer J, Rubeen R, Shakoor S, Khan K, Fatima-Shad K (2025) Glutamate signaling and NMDA receptor dynamics in healthy aging and Alzheimer\u2019s disease. Two sides of the same coin \u2013 neurotransmitters in health and disease. IntechOpen, p 85"},{"key":"6121_CR86","doi-asserted-by":"crossref","unstructured":"Bukke VN, Archana M, Villani R, Romano AD, Wawrzyniak A, Balawender K, Orkisz S, Beggiato S et al (2020) The dual role of glutamatergic neurotransmission in Alzheimer\u2019s disease: from pathophysiology to pharmacotherapy. Int J Mol Sci 23(7):3511.ar Sciences 21(20):7452","DOI":"10.3390\/ijms21207452"},{"key":"6121_CR87","first-page":"1","volume":"21","author":"E Santana-Rom\u00e1n","year":"2025","unstructured":"Santana-Rom\u00e1n E, Soto-Rojas LO, Manjarrez E, Arias-Carri\u00f3n O (2025) Nigrostriatal dopaminergic vulnerability in Parkinson\u2019s disease: neuroprotective strategies. Neural Regen Res 21:1\u201311","journal-title":"Neural Regen Res"},{"issue":"7","key":"6121_CR88","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024240","volume":"7","author":"M Jimenez-Sanchez","year":"2017","unstructured":"Jimenez-Sanchez M, Licitra F, Underwood BR, Rubinsztein DC (2017) Huntington\u2019s disease: mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harb Perspect Med 7(7):a024240","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"18","key":"6121_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/app151810285","volume":"15","author":"JT Johnson","year":"2025","unstructured":"Johnson JT, Awosiminiala FW, Anumudu CK (2025) Exploring protein misfolding and aggregate pathology in neurodegenerative diseases: from molecular mechanisms to clinical interventions. Appl Sci (Basel) 15(18):10285","journal-title":"Appl Sci (Basel)"},{"issue":"2","key":"6121_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020327","volume":"13","author":"K Meng","year":"2025","unstructured":"Meng K, Jia H, Hou X, Zhu Z, Lu Y, Feng Y, Feng J, Xia Y et al (2025) Mitochondrial dysfunction in neurodegenerative diseases: mechanisms and corresponding therapeutic strategies. Biomedicines 13(2):327","journal-title":"Biomedicines"},{"issue":"15","key":"6121_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158132","volume":"25","author":"D Krawczuk","year":"2024","unstructured":"Krawczuk D, Kulczy\u0144ska-Przybik A, Mroczko B (2024) Clinical application of blood biomarkers in neurodegenerative diseases-present and future perspectives. Int J Mol Sci 25(15):8132","journal-title":"Int J Mol Sci"},{"key":"6121_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.797220","volume":"14","author":"R Kacher","year":"2022","unstructured":"Kacher R, Mounier C, Caboche J, Betuing S (2022) Altered cholesterol homeostasis in Huntington\u2019s disease. Front Aging Neurosci 14:797220","journal-title":"Front Aging Neurosci"},{"issue":"15","key":"6121_CR93","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/cells14151161","volume":"14","author":"M Tanaka","year":"2025","unstructured":"Tanaka M (2025) Parkinson\u2019s disease: bridging gaps, building biomarkers, and reimagining clinical translation. Cells 14(15):1161","journal-title":"Cells"},{"issue":"3","key":"6121_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030572","volume":"11","author":"J Liu","year":"2022","unstructured":"Liu J, Zhou F, Guan Y, Meng F, Zhao Z, Su Q, Bao W, Wang X et al (2022) The biogenesis of miRNAs and their role in the development of amyotrophic lateral sclerosis. Cells 11(3):572","journal-title":"Cells"},{"issue":"5","key":"6121_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051045","volume":"13","author":"M Tanaka","year":"2025","unstructured":"Tanaka M, Battaglia S, Liloia D (2025) Navigating neurodegeneration: integrating biomarkers, neuroinflammation, and imaging in Parkinson\u2019s, Alzheimer\u2019s, and motor neuron disorders. Biomedicines 13(5):1045","journal-title":"Biomedicines"},{"issue":"22","key":"6121_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216119","volume":"24","author":"C Toader","year":"2023","unstructured":"Toader C, Dobrin N, Brehar F-M, Popa C, Covache-Busuioc R-A, Glavan LA, Costin HP, Bratu B-G et al (2023) From recognition to remedy: the significance of biomarkers in neurodegenerative disease pathology. Int J Mol Sci 24(22):16119","journal-title":"Int J Mol Sci"},{"issue":"10","key":"6121_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/metabo10100389","volume":"10","author":"A Donatti","year":"2020","unstructured":"Donatti A, Canto AM, Godoi AB, da Rosa DC, Lopes-Cendes I (2020) Circulating metabolites as potential biomarkers for neurological disorders-metabolites in neurological disorders. Metabolites 10(10):389","journal-title":"Metabolites"},{"issue":"3","key":"6121_CR98","doi-asserted-by":"publisher","first-page":"e12490","DOI":"10.1002\/trc2.12490","volume":"10","author":"DC Matthews","year":"2024","unstructured":"Matthews DC, Kinney JW, Ritter A, Andrews RD, Toledano Strom EN, Lukic AS, Koenig LN, Revta C et al (2024) Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer\u2019s disease patients. Alzheimer\u2019s Dement (New York, N.Y.) 10(3):e12490","journal-title":"Alzheimer's Dement (New York, N.Y.)"},{"issue":"3","key":"6121_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/metabo7030042","volume":"7","author":"JF Havelund","year":"2017","unstructured":"Havelund JF, Heegaard NHH, F\u00e6rgeman NJK, Gramsbergen JB (2017) Biomarker research in Parkinson\u2019s disease using metabolite profiling. Metabolites 7(3):42","journal-title":"Metabolites"},{"issue":"2","key":"6121_CR100","volume":"14","author":"S Aqel","year":"2025","unstructured":"Aqel S, Ahmad J, Saleh I, Fathima A, Al Thani AA, Mohamed WMY, Shaito AA (2025) Advances in Huntington\u2019s disease biomarkers: a 10-year bibliometric analysis and a comprehensive review. Biology (Basel) 14(2):129","journal-title":"Biology (Basel)"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06121-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06121-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06121-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T17:02:02Z","timestamp":1786381322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06121-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6121"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06121-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical Trial Number:","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"827"}}